The development of a successful lineage reprogramming strategy of liver to pancreas holds promises for the treatment and potential cure of diabetes. The liver is an ideal tissue source for generating pancreatic cells, because of its close developmental origin with the pancreas and its regenerative ability. Yet, the molecular bases of hepatic and pancreatic cellular plasticity are still poorly understood. Here, we report that the TALE homeoprotein TGIF2 acts as a developmental regulator of the pancreas versus liver fate decision and is sufficient to elicit liver-to-pancreas fate conversion both ex vivo and in vivo. Hepatocytes expressing Tgif2 undergo extensive transcriptional remodelling, which represses the original hepatic identity and, over time, induces a pancreatic progenitor-like phenotype. Consistently, in vivo forced expression of Tgif2 activates pancreatic progenitor genes in adult mouse hepatocytes. This study uncovers the reprogramming activity of TGIF2 and suggests a stepwise reprogramming paradigm, whereby a ‘lineage-restricted’ dedifferentiation step precedes the identity switch.
Successful lineage reprogramming relies on the identification of defined factor(s) able to establish the new cell fate transcriptional program and, concomitantly, silence the original gene expression program1,2,3,4. Here, we sought to investigate cellular plasticity between liver and pancreas and to what extent this enables their fate interconversion.
Lineage reprogramming holds distinct advantages over stem cell-based replacement strategies, with the new cells being autologous in origin, residing within their native tissue, and with a theoretically lower risk of tumorigenesis5. Recent studies have unveiled an unsuspected degree of cellular plasticity in the adult pancreas and pointed to pancreas-resident cells as potential sources for new β-cells6,7,8,9,10,11,12,13,14,15. However, from a clinical perspective, adult liver cells hold important advantages over pancreatic cells, representing a more accessible and abundant starting cell population for fate conversion approaches to generate pancreatic cells with therapeutic potential3,16. To date, adenovirus-mediated ectopic expression of pancreatic transcription factors (TF) (for example, Pdx1, Ngn3) in the liver has been shown to partially correct hyperglycaemia in diabetic mice, even though the phenotypic conversion appears incomplete17,18,19,20. Moreover, delivery of the same pancreatic TFs through adeno-associated viruses (AAV), which have low-immunogenity but high-transduction efficiency, or upon transgene expression in mice did not exert the same effects19,21,22. These observations are consistent with the fact that the two lineages are closely related but yet at a greater distance than cells of the same lineage, for example, exocrine and endocrine pancreas cells23,24. Additional limitations might be the lack of appropriate interaction partners or the presence of antagonistic factors in liver cells that lock cell identity, hampering cell plasticity and conversion. To overcome these lineage restrictions, we investigated whether developmental regulator(s) of the pancreas versus liver fate decision might be effective reprogramming determinants for achieving conversion of liver cells into pancreas fate.
The transcriptional mechanisms underlying hepatic and pancreatic lineage divergence in the mouse embryo begin to be unravelled25,26,27. In a RNASeq gene expression profile of liver and pancreas progenitor cells isolated from the mouse embryo, we identified the Three-Amino-acid-Loop-Extension (TALE) homeobox TG-interacting factor 2 (TGIF2) at the cell-fate branchpoint, being in the common endoderm progenitor pool and whose expression changes in opposite directions as cells commit to pancreatic or hepatic lineages25,28. TALE proteins are involved in many crucial developmental processes and diseases through their function as Hox-transcriptional co-regulators, but also through Hox-independent mechanisms29,30. TGIF2 contains a highly conserved homeodomain and has been described as a context-independent transcriptional repressor, exerting its function either through modulation of the BMP/TGF-beta pathway or through direct DNA binding28,31. In Xenopus embryos, Tgif2 acts as an intracellular endodermal effector promoting pancreatic fate by inhibiting BMP signalling28. In the mouse embryo, overlapping functions between Tgif2 and its close family member, Tgif1, have been previously reported during different embryological processes, such as gastrulation and neural development32,33.
Here, we demonstrate that TGIF2 is a developmental regulator of pancreas versus liver fate decision using both loss- and gain-of function experiments in mouse embryos and embryonic stem (ES) cells, respectively. In addition, when ectopically expressed in murine adult liver cells, TGIF2 promotes suppression of the hepatic transcriptional program and induction of a subset of pancreatic genes. Overall, hepatocytes expressing Tgif2 acquire a pancreatic progenitor state and upon exposure to pancreatic microenvironment or in vivo transplantation into diabetic mice the reprogrammed cells undergo further differentiation and acquire certain functional pancreatic properties. Similarly, in vivo AAV-mediated Tgif2 expression in adult mice turns on marker genes of the pancreatic lineage in hepatocytes. In summary, this study defines a novel strategy for controlled generation of pancreatic progenitors based on TGIF2-dependent fate conversion and opens to new investigation into the mechanistic aspects of cellular identity and plasticity.
Liver and pancreas fate divergence
The TALE class of homeodomain-containing TFs are known to play crucial roles in establishing cell identity and organogenesis, including pancreas formation28,29,34. We found that foregut endoderm progenitors express elevated Tgif2 levels, which is in line and validated previous RNASeq data25 (Fig. 1a; Supplementary Fig. 1a). Importantly, at the 2-somite (S) stage (E8.0) Tgif2 expression was spatially confined to the caudo-lateral region of the ventral foregut, which is the location of presumptive bipotent hepatic and pancreas progenitors (Fig. 1c)35. Subsequently, by 7–9S stage (E8.5), whole-mount immunofluorescence (IF) showed co-localization of TGIF2 with PROX1 in ventral pancreatic progenitors at the lip of the foregut but not in hepatoblasts (Fig. 1b). After the fate decision between liver and pancreas is made, Tgif2 exhibited high and persistent expression levels in pancreas throughout embryonic development, as well as in adulthood, whereas it was undetectable in the liver (Fig. 1; Supplementary Fig. 1b,c).
Because of its restricted expression in the ventral foregut, we asked whether Tgif2 regulates the allocation of foregut progenitor cells into pancreas fate and is sufficient for the activation of pancreatic transcriptional program. The closely related family member, Tgif1, does not display a similar restricted expression, being in both hepatic and pancreatic progenitor cells25. However, given the high degree of functional overlap between Tgif2 and Tgif1 during mouse embryogenesis29,33, we conditionally deleted Tgif2 in the epiblast using a loxP-flanked Tgif2 allele36 and the Sox2-Cre transgene37 in a Tgif1-deficient background32 (Fig. 2; Supplementary Fig. 1d). No double homozygous mutant embryos (Tgif2r/r;Tgif1−/−;Sox2-Cre) were found in our genetic background (0 out of 216 embryos), hampering a complete loss-of-function analysis (Supplementary Fig. 1d). However, the presence of one single wild-type allele of either Tgif1 or Tgif2 gene supported normal embryonic development to at least E10.5, enabling the analysis of ventral foregut organogenesis (Fig. 2). We analysed the expression of Pdx1 and Sox17, which is involved in the segregation between liver and pancreatobiliary systems and expressed in ventral pancreatic progenitors from E9.5 onward38,39,40,41. Interestingly, mouse embryos with Tgif combined mutations, homozygous for one gene and heterozygous for the other (for example, Tgif2r/+;Tgif1−/−;Sox2-Cre or Tgif2r/r;Tgif1+/−;Sox2-Cre), showed consistent reduction of the SOX17+ and PDX1+ ventral pancreatic buds at E9.5 (Fig. 2a,b). This was accompanied by an expansion of the hepatic bud volume, as measured by PROX1 staining (Fig. 2a,b).
Next, we directly assayed Tgif2 for pancreatic fate-inducing activity. To model ex vivo endoderm development and specification of pancreas progenitors, we used a directed stepwise differentiation system of mouse embryonic stem cells (ESC), adapted from previously published studies25,42,43. Monolayer cultures of mES cells were first differentiated into definitive endoderm (DE), transduced with a bicistronic lentiviral vector (LV) expressing Tgif2 and the reporter enhanced green fluorescent protein (EGFP) genes, and then differentiated into pancreatic endoderm (PE) (Fig. 1d; Fig. 3a). We found that Tgif2 enhanced differentiation of the DE-induced population toward pancreatic fate, as judged by the further increase in expression levels of Sox17, Pdx1 and Hnf1b (Fig. 1d). Conversely, when DE cells were differentiated into hepatic endoderm (HE)44 in the presence of Tgif2, we observed marked decrease in the expression of liver-specific genes (for example, Serpina1, Hnf4a, C/EBPa) (Fig. 1d). Taken together, our results indicate that TGIF2 acts as a developmental regulator of the hepatopancreatic lineage, pushing foregut progenitors toward pancreatic cell fate and counteracting hepatic fate. Thus, these properties make TGIF2 a pertinent candidate to be tested for lineage reprogramming of liver to pancreas.
Stepwise reprogramming of liver cells to pancreas progenitors
To assess this possibility, first we developed an ex vivo lineage reprogramming strategy based on LV vectors for stable and sustained expression of Tgif2 in liver cells. We expressed Tgif2 in primary mouse hepatocytes (HEP) that were freshly isolated from adult livers and cultured in standard hepatocyte culture medium (Fig. 3a; Supplementary Fig. 2e). At one week after transduction with LV-TGIF2, we measured robust ectopic Tgif2 expression and concomitant repression of liver-specific genes, including Albumin, Serpina1 and Transthyretin (Ttr), and the TFs Hex, Hnf4a and Hnf4a1 liver-specific isoform (Fig. 3b). Two weeks post-transduction, the depletion of hepatic transcripts was maintained (Fig. 3b) and accompanied by induction of pancreatic progenitor genes, such as the TFs Pdx1, Ptf1a, Neurod1, Pax6, MafA, Isl1, and Insm1 (ref. 23), as well as Nestin, encoding an intermediate filament protein, which marks undifferentiated pancreatic precursor cells at E10.5 (ref. 45) (Fig. 3b; Supplementary Fig. 2f). Notably, the expression of all these pancreatic TFs, besides Pdx1 and Ptf1a, begins at the onset of pancreatic bud formation by E10.5 and later is restricted to the endocrine cell population23,25. LV-TGIF2 did not affect the expression levels of endogenous Tgif2 or Tgif1 (Supplementary Fig. 2g).
Prolonged analysis of the LV-TGIF2-transduced cells beyond 2 weeks was not possible because of the limited viability of primary HEP cultures in vitro46,47. To overcome this problem, we used the well-characterized non-transformed BAML hepatic cell line48, as an additional ex vivo model system. The BAML is a cell line established from adult wild-type mouse liver that was previously shown to repopulate the liver in vivo48. This cell line displays various mature hepatic features, including expression levels of Albumin, Serpina1, Ttr, Fah, which are comparable to those in the adult mouse liver (Supplementary Fig. 2a). However, the level of important enzymes in glucose homoeostasis, such as G6pc and Pepck, and members of the cytochrome P450 family, such as Cyp3a11, is lower than in adult mouse liver, while biliary epithelial markers Cytokeratin 7 and 19, are present in BAML, like in bi-potential hepatic progenitor cells (Supplementary Fig. 2a). We cultured the BAML hepatic cells in their standard hepatocyte culture medium and characterized them after transduction with either LV-TGIF2 or LV-GFP, as control, at multiple time points ex vivo, as well as in vivo (Fig. 3c; Supplementary Fig. 2b). Tgif2-expressing cells proliferated at a lower rate than controls during the first week after transduction and reacquired the normal proliferative activity after 10 days (Supplementary Fig. 2c,d). At early time points (1 and 2 weeks), ectopic Tgif2 expression in BAML HEP cells elicited effects similar to those observed in primary HEPs, including strong reduction of the hepatic gene expression program and subsequent induction of a set of pancreatic genes (Fig. 3c). Importantly, the levels of pancreatic transcripts either remained stably induced or increased (for example, Pdx1 and MafA) over time (day (d) 30 and d50 time points after Tgif2 expression) (Fig. 3c). Repression of the hepatic gene expression program was also maintained in long-term cultures of LV-TGIF2-tranduced BAML HEP cells, even though it became less prominent after d50, suggesting possible occurrence of culture heterogeneity (Fig. 3c).
IF analysis corroborated these findings, showing LV-TGIF2-transduced BAML HEP cells positive for GFP that were also positive for SOX9 and/or PDX1 but displayed reduction or loss of hepatic differentiation markers (albumin and glutamine synthetase (GS)) (Fig. 3d). Three weeks after transduction, a typical TGIF2-LV culture was composed of 50±4% SOX9-positive cells, 8.75±1.23% PDX1-positive cells and 48.10%±3.84% of the PDX1-positive cells also co-express SOX9. Notably, PDX1-positive cells were not simultaneously positive for liver markers, such as albumin or GS, excluding hybrid cellular phenotypes in LV-TGIF2 HEP cultures (Fig. 3d). As expected, control BAML HEP cultures displayed typical abundant cytoplasmic albumin or GS in the absence of pancreatic markers (Fig. 3d).
TFs in common between the two fates, such as Prox1 and Foxa2, were expressed at similar levels in both control and Tgif2-expressing HEP cells (Fig. 3c). Induction of marker genes for stomach, duodenal and intestinal fates (for example, Sox2, Nkx6.3 and Cdx2) was not detected in Tgif2-expressing HEP cells (Fig. 3b,c; Supplementary Fig. 3a,b). Moreover, induction of pancreatic fate was not accompanied by the activation of a facultative liver stem/progenitor population (for example, Lgr5-positive)49, pluripotency markers or other lineage-specific transcripts, suggesting a fate-restricted switch (Fig. 3b; Supplementary Fig. 3). Remarkably, we also observed induction of endodermal genes, such as Gata6 and Cxcr4, as well as of Pdx1 and Ptf1a expression when LV-TGIF2 was transduced in adult mouse fibroblasts, suggesting a potential broader reprogramming activity of TGIF2 also in non-endodermal lineage cells (Supplementary Fig. 3c).
Altogether these data show that Tgif2 is uniquely able to rapidly down-regulate the typical hepatic gene regulatory network and promote a pancreatic progenitor gene-expression signature even in conditions that favour hepatic cell maintenance. We then tested if LV-TGIF2-transduced primary HEPs grow and expand in three-dimension (3D) culture conditions that have been recently established for pancreas progenitor cells50. We found that TGIF2-LV primary HEPs formed organoids, which were composed of SOX9- and PDX1-positive cells (Fig. 4a,b). By contrast, control non-transduced primary HEPs did not cluster to form 3D aggregates under the same pancreatic conditions and failed to grow (Fig. 4a). Next, to start testing the differentiation potentials of the organoids established from TGIF2-LV primary HEPs, we transplanted them into fresh E12.5 mouse pancreatic explants (Fig. 4c). Importantly, when exposed to their native pancreatic microenvironment, the grafted progenitor cells (GFP-positive) either expressed pancreatic progenitor markers (PDX1, NKX6.1) or retained the potential to differentiate and expressed acinar (AMYLASE) or endocrine (INSULIN, GLUCAGON) markers (Fig. 4c). Endocrine differentiation of GFP-positive grafted progenitor cells was more frequent into glucagon+ cells, resulting in average of ∼30% GLUC+/GFP+ versus 10% INS+/GFP+, while exocrine cells were less frequent (Fig. 4c). Altogether, these results indicate that in the presence of TGIF2 mature hepatocytes acquire a typical pancreatic progenitor gene expression signature and can further differentiate as true progenitor cells. Reprogrammed primary and BAML HEP cells are hereafter referred to as TGIF2-induced Pancreatic Progenitor (TiPP) cells.
Tgif2-reprogramming induces gene expression remodelling
Next, we analysed the changes in global gene expression in reprogrammed TiPP cells. We compared the gene expression profiles of FACS-purified TiPP cells at two time points (d14 and d30 post-transduction), control BAML HEP cells, mouse embryonic pancreas (E14.5) and adult pancreas and liver tissues. Unsupervised hierarchical clustering of gene expression data showed a clear relationship between reprogrammed TiPP cells and E14.5 mouse pancreas (Fig. 5a). As expected, the control BAML HEP population clustered together with adult liver (Fig. 5a). Notably, typical representative genes, which define pancreatic progenitor identity, including Sox9, Pdx1, Pax6, Cpa1, Nr5a2, Neurod1, Tead2, Tle2, Tle3, were upregulated in TiPP cells, whereas all well-known genes involved in hepatic functions, such as cytochrome enzymes, apolipoproteins and detoxification enzymes, were down-regulated (Fig. 5b).
Embryonic pancreas and liver share many common features, which is reflected by the similarity of their transcriptome profiles24 (Supplementary Fig. 4). To measure to what extent TiPP cells are closer to pancreatic or hepatic progenitors, we first focused on the initial events of reprogramming (at d14 time point) and examined the overlap between the gene expression-signature of mouse E10.5 FACS-purified pancreatic and hepatic progenitors25, TiPP d14 and control population transcriptomes (Supplementary Fig. 4a,b). We found that more than 50% of the pancreas progenitor genes were upregulated in TiPP d14 cells, indicating a significant overlap (FC>2, P value <0.05, Benjamini–Hochberg method) despite the methodological differences (Supplementary Fig. 4a). By contrast, only 4% of E10.5 hepatic genes were upregulated in TiPP cells (FC>2, P value <0.05) (Supplementary Fig. 4b). Similarly, the comparison of the expression profiles of reprogrammed cells with mouse embryonic liver and pancreas at later stages (E13.5–E14.5) showed that TiPP cells gained a larger fraction of pancreatic-specific markers compared with hepatoblast-specific markers (Supplementary Fig. 4c,d). Thus, the reprogramming event was broadly reflected in global gene expression changes, suggesting that TiPP cells are similar to mouse pancreatic progenitors.
Analysis of gene ontology terms enrichment of differentially regulated TiPP genes revealed an upregulation for genes involved in developmental processes, cell adhesion and transcription, while genes involved in metabolic and transport processes were downregulated (Supplementary Fig. 4f; Supplementary Data 1). This is in line with the robust inhibition of typical hepatocyte functions (Fig. 5b). Interestingly, the analysis of enrichment of Panther pathway annotations pointed to genes involved in the Wnt signalling pathway (23 genes; P value, 0.00043) (Fig. 5c). In particular, we found that many Wnt/Planar cell polarity core genes, such as Vangl, Celsr, Prickle1 and Scrib, as well as downstream Wnt transducers, such as Tcf7, Nfatc2, Camk2b and Tle3, were upregulated in reprogrammed cells (Fig. 5d,e). These findings are consistent with the previously recognized role for non-canonical Wnt in pancreas and liver cell lineage divergence and imply concurrent changes in epithelial cell polarity during liver-to-pancreas fate conversion, as seen in the embryo25,51. Finally, since TGIF2 is a known regulator of TGF-β and BMP signalings28,33, we searched for potential modulation of their target genes in TiPP and control population transcriptomes. We observed a strong downregulation of well-known direct BMP targets (Id1 and Id2) in TiPP cells, while the effect on TGF-β target genes is less prominent (Supplementary Fig. 4e). These findings are consistent with previous reports on TGIF transcriptional regulation of BMP/TGF-β signalling28,33 and the role of BMP in pancreas versus liver fate decision24.
Induced pancreatic progenitors differentiate in vivo
A stringent test routinely used for pancreatic progenitor cells obtained in vitro is whether they ‘mature’ to functional cells when implanted in vivo42,43. To assess the in vivo differentiation potential of the reprogrammed-derived pancreatic progenitors, we engrafted the TiPP cells (1 × 106 cells) under the kidney capsule (KC) of hyperglycemic Akita mice. Islets from Akita heterozygous mice are depleted of β-cells, and those remaining release very little mature insulin, representing an excellent mouse model of diabetes52. We found that blood glucose levels improved soon after transplantation of TiPP cells and remained stable over the eight weeks duration of the experiment (Fig. 6a), displaying an effect comparable to the transplantation of 100–200 mouse islet equivalent (IE) (Supplementary Fig. 5). IF analysis revealed that TiPP cells implanted under the KC organized themselves into epithelial structures, which were positive for PDX1 and SOX9 or for typical molecular features of pancreatic β-cells, such as GLUT2, insulin, C-peptide, prohormone convertase (PC) 2 and urocortin 3 (UCN3) (Fig. 6b; Supplementary Fig. 5e). In particular, within the grafts ∼30% INS-positive cells were detected, (29±2%), reflecting the efficiency of differentation of TiPP cells upon engraftment. By contrast, neither amylase nor other endocrine hormones were detected in the grafted TiPP cells (Supplementary Fig. 5d). Akita mice transplanted with BAML HEP cells transduced with control LV-GFP displayed higher levels of glycaemia throughout the assay and did not acquire pancreatic differentiation features in the KC mesenchyme (Fig. 6a,b; Supplementary Fig. 5). No tumours were observed after eight weeks posttransplantation. These results indicate that pancreatic progenitors derived from reprogrammed hepatic cells are ‘poised’ for further differentiation along the endocrine β-cell lineage when exposed to the appropriate environment. Nevertheless, the obtained insulin-producing cells are likely immature beta-like cells and do not fully recapitulate functional capacity of mature beta-cells.
In vivo induction of pancreas progenitors
Given its remarkable ex vivo reprogramming activity, we next assessed whether TGIF2 might induce a pancreatic program in vivo directly in the native liver environment. To exclusively target hepatocytes, we ectopically expressed Tgif2 using recombinant AAV2/8 vector, which exhibits hepatocyte-specific tropism and rapid clearance, and combined it with the hepatocyte-specific thyroid-binding globulin (TBG) promoter53 (Fig. 7a). Livers from adult animals administered with AAV8.TBG-Tgif2 were collected at different time points after delivery and examined for cellular identity by RT-qPCR and IF analyses (Fig. 7a–c; Supplementary Figs 6–8). Normal tissue-architecture was preserved in AAV-injected livers, as judged by their lobular organization along the porto-central axis and distinct periportal and perivenous gene expression patterns (Fig. 7c; Supplementary Figs 6 and 7). Notably, within one week of AAV8.TBG-Tgif2 injection, we detected ectopic SOX9-positive cells throughout the liver parenchyma (Fig. 7c,d), including in the perivenous ‘zone 3’ of the liver that is close to the central vein and positive for GS, whereas in adult livers under normal conditions SOX9 marks only biliary epithelial cells (bec)26,49,54,55 (Fig. 7c). Ectopic SOX9 activation in hepatocytes of AAV8.TBG-Tgif2-injected livers was not accompanied by expression of bec markers (for example, Epcam, Osteopontin and CK19)47,53,54, excluding the induction of biliary fate (Fig. 7c; Supplementary Fig. 7a). One month post-AAV injection, we observed induction of PDX1 expression in a subset (18%) of SOX9-positive cells as well as additional pancreatic TFs, such as NeuroD1 and Nkx6.1 (Fig. 7c,d), but neither endocrine nor exocrine differentiation functions (Supplementary Fig. 7b) in the livers of AAV8.TBG-Tgif2-injected animals. AAV injection itself (for example, AAV.GFP) did not induce ectopic activation of pancreatic genes in hepatocytes (Fig. 7c,d; Supplementary Fig. 6c). Next, we asked whether environmental cues, such as a hyperglycemic state, might promote maturation of the Tgif2-induced pancreatic progenitor-like cells in vivo too. AAV8.TBG-Tgif2 was injected into diabetic Akita heterozygous mice, blood glucose levels and insulin concentration were measured at d60 after AAV delivery (Supplementary Fig. 6e,f). While blood glucose levels remained elevated in non-treated and AAV.GFP-injected Akita mice, a group of AAV.TGIF2-treated Akita animals (4 out 7) showed sustained decrease in blood glucose, which was accompanied by higher levels of circulating insulin (Supplementary Fig. 6e,f). The others remained hyperglycemic with low insulin levels. Altogether, these results indicate that ectopically expressed TGIF2 exerts similar activity in vivo, being sufficient to induce typical pancreatic progenitor genes expression, during normal adult liver homoeostasis.
Our data show that TGIF2 functions as a versatile reprogramming factor, exerting a twofold activity: it unlocks and represses hepatic identity and establishes pancreatic cell identity. Hepatic cells undergoing fate switching pass through an intermediate state that lacks characteristics of both the initial and final cellular identities, a so-called dedifferentiation step. Importantly, we found that this intermediate state is not widely plastic and Tgif2-expressing cells are instead ‘lineage-restricted’ toward the pancreatic progenitor fate, without reverting to pluripotency or switching to other closely related lineages. Moreover, given the fact that adult hepatocytes are differentiated and arrested in quiescence (G0 phase), the change in cell identity triggered by Tgif2 occurs in the absence of cell division (Supplementary Fig. 8), possibly implying a direct fate transitioning through discrete steps.
Previous liver-to-pancreas reprogramming studies used adenovirus vectors to force the expression of pancreatic TFs (for example, Pdx1, Ngn3) in the liver in vivo or hepatic cell cultures17,18,20. These studies mostly focused on the acquisition of insulin expression and some other markers of pancreatic identity, but they did not assess the degree of loss of hepatic fate and did not follow the fate transition (liver to pancreas) temporally. Importantly, in the strategy presented here, we showed that TGIF2 first represses hepatic gene expression, which is followed by induction of pancreatic progenitor genes. Such temporal succession of the events is a prerequisite to avoid aberrant hybrid cellular states in lineage reprogramming. In addition, in previous studies the forced expression of pancreatic TFs seems to work only under certain conditions that might be favourable to cellular transdifferentiation17,18,20. For instance, adenovirus-mediated delivery of Pdx1 or Ngn3 was shown to induce insulin expression by the liver, whereas AAV-mediated overexpression of the same TFs did not result into insulin production or correction of diabetes in mice19. These observations suggest that adenoviruses may facilitate cellular reprogramming, possibly because of their ability to induce general inflammatory responses, which is instead absent upon AAV gene transfer19,56. It is therefore crucial to assess the exact contribution of the reprogramming factor(s) itself in the absence of an inflammatory microenvironment. For this reason, in our novel strategy we assessed the specific reprogramming activity of TGIF2 using independent in vivo and ex vivo approaches and different delivery methods, including AAV under liver homoeostasis.
TGIF2 has been characterized as a context-independent transcriptional repressor, being able to exert its function either through modulation of the BMP/TGF-beta pathway or direct DNA binding28,29,31. Interestingly, the transcriptome analysis of the TiPP cells shows a higher number of upregulated than downregulated genes (470 out of 592 differentially regulated genes; P<0.01, FC<−4 or >4). If TGIF2 acts solely as a repressor, one possible mechanism of action to achieve activation of so many genes would be through the repression of a repressor. Alternatively, TGIF2 may function simultaneously as both an activator and repressor of genes during reprogramming. This is indeed a common feature of other TALE homeoproteins to act both as transcriptional repressor or activator in a context-dependent manner, for example, depending on cellular environment and binding partners29,30. Systematic characterization of TGIF2-mediated transcriptional activity will establish if this is the case also for this homeoprotein.
Reprogramming of hepatic cells to a pancreatic identity presents a valuable model to study hepatopancreatic plasticity and to identify by which mechanism each fate is established and maintained. Consistently, we identified a subset of molecular networks that are activated both in TGIF2-induced reprogramming as well as during liver and pancreas fate decision in the embryo. For instance, the enrichment of numerous non-canonical Wnt players in TiPP cells is consistent with the RNA-Seq profiling of mouse pancreatic and hepatic progenitor cells at the time of their lineage divergence25. In addition to Wnt modulation, we found robust and stable upregulation of Fgfr1 and some of its well-known downstream signal transducers, including Akt3, Plcg2, Mapk12, in the reprogrammed TiPP cells when compared with control hepatocytes (Supplementary Table 1). Recent observations identified a regulatory loop between SOX9 and FGF signalling in the early pancreatic niche that is required to repress liver-specific gene expression program and ensure pancreatic fate identity at early time point57. Thus, our findings suggest that TGIF2 may install a similar circuit between SOX9 and Fgfr in hepatocytes that undergo reprogramming, recapitulating the same in vivo mechanisms. Notably, we also found induction of the transcription factor Tead2 in TiPP cells at early stage of reprogramming. This is in in line with the Teads being pancreatic progenitor-enriched factors in the mouse embryo25 and human pancreatic progenitors58, where they act as integral components of the pancreatic lineage-specific transcriptional program, regulating SOX9 and FGF receptors58.
From a broader perspective, the reported TGIF2-mediated stepwise fate conversion affords a unique opportunity to decipher genetic and epigenetic changes during the intermediate states of liver-to-pancreas reprogramming. This might also shed light on more fundamental reprogramming mechanisms. Indeed, fate conversion via a ‘tissue-restricted’ dedifferentiation step, which precedes re-differentiation into the new cell type, has been reported in natural transdifferentiation events in worms59, as well as during limb regeneration in the axolotl (ref. 60), suggesting possible common themes in reprogramming and regeneration across phyla. The knowledge gained from these experimental manipulations will have broad implications not only for understanding the molecular basis of cellular identity and plasticity, but also for potential clinical application. Ultimately, the stepwise TGIF2-dependent fate conversion represents a novel strategy for controlled generation of pancreatic progenitors from liver and, possibly, a starting point for future production of pancreatic β-cells suitable for therapeutic use in diabetic patients.
Cell culture and viral infection
Mouse ES cells (R1 line)61 were maintained on gelatin-coated plates with inactivated mouse embryonic fibroblasts (MEFs) in standard mESC medium (High Glucose DMEM (Invitrogen) supplemented with 15% Fetal Calf Serum (FCS) Gold Serum (PAA), non-essential amino acids (Invitrogen), 1% Penicillin/Streptomycin (Invitrogen), 10 mM sodium pyruvate (Invitrogen), 1% Glutamax (Invitrogen), 50 μm 2-mercaptoethanol (Invitrogen)) and 1,000 U ml−1 leukaemia inhibitory factor (ESGRO). For differentiation, cultures were MEF-depleted and seeded in mESC medium at high-confluence on gelatin-coated dishes. Monolayer differentiation was carried out as following42,43: DE medium to day 2 consisted of RPMI medium (Invitrogen) and 0.2% FCS supplemented with 50 ng ml−1 Activin A and 25 ng ml−1 Wnt3a at day 1 and Activin A only at day 2. PE medium to day 8 consisted of RPMI medium and 2% FBS supplemented with 3 ng ml−1 Wnt3a and 50 ng ml−1 FGF10 (refs 42, 43). HE medium to day 8 consisted of RPMI medium and 2% FBS supplemented with 1% B27, 10 ng ml−1 basic FGF and 20 ng ml−1 BMP4 (ref. 44). All recombinant proteins were purchased from R&D System unless otherwise stated. Plateable male mouse CD-1 cryopreserved primary hepatocytes (Life Technologies) and BAML cells were cultured on Collagen I-coated plates in hepatocyte medium48 (referred to as ‘HEP medium’), which consists of William’s E medium without phenol red (Sigma), 1% Penicillin/Streptomycin, 1% Glutamax, 10% FCS, 30 ng ml−1 IGF II (Peprotech), 50 ng ml−1 EGF (R&D), 10 μg ml−1 Insulin (Peprotech), 0.1 μm dexamethasone and 10 mM nicotinamide. Mouse adult fibroblast cultured were established from tail biopsies and cultured in DMEM supplemented with 10% FCS. Cell lines were routinely tested for normal karyotype and mycoplasma. Cells were infected with pPGK-TGIF2-2A-EGFP lentiviral expression vector (LV-TGIF2) at multiplicity of infection (MOI) of 40. The pPGK-TGIF2-2A-EGFP lentiviral expression vector (LV-TGIF2) was generated by cloning the cDNAs of mouse Tgif2 and EGFP, linked by the T2A self-cleaving sequence, into the pRRL.SIN.cPPT.PGK-GFP.WPRE lentiviral plasmid vector (Addgene plasmid 12252).
For FACS isolation, hepatic cell suspensions were first filtered through a BD Falcon tube with cell strainer cap (BD 352235). Before sorting, propidium iodide (PI) was added to exclusively select live cells. After dead cell exclusion (SSC-A/PI-A), GFP-expressing cells were sorted using a FACS Aria I flow cytometer (BD Biosciences) using a GFP filter and setting the gate on the GFP fluorescence intensity. For cell cycle analysis, cells were fixed in 70% ethanol overnight and incubated with 100 μg ml−1 RNase A and 40 μg ml−1 PI for 30 min at 37 °C. The cell cycle profile was analysed using the BD LSRFortessa cell analyser. For generation of the growth curve, cells were seeded on collagen-coated plates on day 12 post-transduction at a density of 2.5 × 104 cells per well. The medium was changed daily, and the cell number was counted every day for one week.
3D culture and transplantation assay in explants
For 3D-differentiation50 control primary hepatocytes or after transduction with LV-TGIF2 were dissociated and about 8–10 cells per μl mixed with Matrigel (BD Biosciences) at a ratio 1:3 and plated in pancreas progenitors culture conditions50. For transplantation assay into pancreatic explants, LV-TGIF2-organoids after 6 days in culture were roughly dissociated in 0.05% trypsin and injected into the recipient explants with a mouth pipette. E12.5 pancreatic explants were isolated and cultured as described in ref. 62. After engraftment, the explants were cultured for 4 days, fixed in 4% paraformaldehyde and analysed by immunofluorescent staining. The experiment was repeated twice with a total of 28 TGIF2-organoids successfully grafted into recipient pancreatic explants63.
Immunohistochemistry and in situ hybridisation
Mouse embryos and tissues were fixed in 4% paraformaldehyde at 4 °C from 2 h to overnight. For cryosectioning, samples were equilibrated in 20% sucrose solution and embedded in OCT compound (Sakura). Whole-mount in situ hybridisation and in situ hybridisation on cryostat sections (10 μm) were performed according to ref. 28. For whole-mount immunostainings fixed mouse embryos were bleached for 1–2 h in 6% hydrogen peroxide solution, incubated in freshly prepared PBSMT blocking solution (2% milk powder, 0,5% TritonX-100 in 1 × PBS), and afterwards with primary antibodies at the appropriate dilution ON at 4 °C (see Supplementary Table 2). After extensive washes in fresh PBSMT solution at least 5–8 times, the embryos were incubated overnight with secondary antibodies at 4 °C in PBSMT solution25,64. Whole mouse embryos from E 9.5 onward were cleared in methyl salicylate for confocal microscope imaging. For immunostaining, cryosections were incubated with TSA (Perkin-Elmer) blocking buffer for 1 h at room temperature and afterwards with primary antibodies at the appropriate dilution (Supplementary Table 2). If necessary, antigen retrieval was performed by boiling the slides for 20 min in citrate buffer (Dako). For IF on cultured cells, cells were grown on coverslips, fixed in 4% paraformaldehyde for 20 min at RT and permeabilised in 0.2% Triton X-100 in PBS. Images were acquired on Zeiss AxioObserver and Zeiss LSM 700 laser scanning microscope. Huygens software (SVI) was used for 3D volume measurement analysis of confocal z-stacks of mouse embryos. For quantification of SOX9− and PDX1-positive cells, one entire lobe of AAV-injected and uninjected livers were sectioned, sampled at a minimum of every 150 μm and processed by immunohistochemistry. Liver sections were acquired using tile scan (mosaic) function on a Zeiss LSM 700 laser scanning microscope, cells were counted from digitized micrographs and area (Hoechst-positive) measured using ImageJ or Axiovision softwares. Sections were counted from at least three animals per condition. Values presented are the average cell number relative to the area of liver section (mm2). Student’s t-test was used for statistical analysis.
RT-qPCR and transcriptome analysis
RNA was isolated using RNAzol (Biozol) or High Pure RNA Isolation Kit (Roche). Total RNA was processed for reverse transcription (RT) using Transcriptor First Strand cDNA Synthesis Kit (Roche). Real-time PCR reactions were carried out using the SYBR Green Master Mix (Roche) on ABI StepOne Plus system. Succinate dehydrogenase (SDHA) or 36B4 were used as reference genes. Primer sequences are provided in Supplementary Table 1. Technical triplicates were run for all samples and ‘no RT’ and no template controls were included in all experiments. All the values were normalized to the reference genes and calculated using the software REST63. qPCRs were performed for 40 cycles. ‘Undetermined’ data points were assigned a Ct of ‘40’ to enable calculation of fold change. Also, reactions with Ct-values equal to the ‘no RT’ control reaction were considered as ‘negative’ and the values used for calculating fold changes. Statistical significance in qPCR experiments was calculated using the REST randomization test63. Whole transcriptome analysis was performed on Agilent SurePrint G3 Mouse GE 8 × 60 K Microarray Kits at the MPI Array Facility, Dresden. The single colour signals were read using Agilent Feature Extraction Software. All bioinformatics analyses were performed using R (http://www.r-project.org). Differential gene expression was determined using the R statistical package limma65. Expression values were scaled per row by Z-score (row average equals zero (white); positive or negative values indicate how many standard deviations the value is located above (red) or below (blue) the mean, respectively). Adjusted P values were corrected for multiple testing using the Benjamini–Hochberg method. Gene Ontology analysis was performed using the Genecodis application66.
C57BL/6-Ins2Akita/J (ref. 52), TGIF1tm1aPah (ref. 51) and Tg(Sox2-cre)1Amc/J (ref. 37) (JAX laboratories) mouse strains were previously described. The mouse TGIF2tm1a(EUCOMM)Wtsi strain was generated at the ICS using the EUCOMM embryonic stem (ES) cell collection36. All animal experimentation was carried out in accordance to the local ethics committee for animal care.
Transplantation underneath the kidney capsule
Spontaneously diabetic 8–9 weeks old C57BL/6-Ins2Akita/J female mice were used as recipients. 100–200 mouse IE or 1 × 106 FACS-sorted cells were collected and transplanted under the kidney capsule, according to previously reported procedures67. Blood glucose was measured at 12 h intervals over the first two days post-transplantation and biweekly thereafter. After 8 weeks, the graft-bearing kidneys were removed and fixed overnight in 4% formalin at RT. Samples were embedded in paraffin for histological analysis.
The adeno-associated viral construct AAV8.TBG.TGIF2 was generated by cloning mouse Tgif2 cDNA into the pENN.AAV2/8.TBG.PI.RBG plasmid vector (PennVector p1015). Replication-incompetent AAV8.TBG.TGIF2 and AAV8.TBG.eGFP AAVs were produced at the Penn Vector Core facility. 2–4 × 1011 particles of adeno-associated virus diluted in sterile PBS were administered per adult mouse (C57BL/6 and C57BL/6-Ins2Akita/J strains) by tail vein injection.
Glucose tolerance test
Glucose tolerance test (GTT) was carried out on animals that had been fasted overnight, before the day of experimentation (time point −1). Animals were injected i.p. with glucose (2 g kg−1 body weight). Glucose levels were measured from blood collected from the tail immediately before the glucose challenge (time point 0) and 15, 30, 60, 120 and 240 min after the glucose injection using a blood glucose metre (Contour, Bayer). Serum insulin concentration was measured with the Ultra Sensitive Mouse Insulin ELISA kit (Crystal Chem. #90080).
All results are expressed as mean±s.e. (s.e.m.). Sample sizes of at least n=3 were used for statistical analyses except where indicated. The significance of differences between groups was evaluated by two-tailed unpaired Student’s t-test or, when more than two groups were assessed, by ANOVA test. P<0.05 was considered statistically significant. Statististical tests relevant to the qPCR and microarray experiments are described in the ‘RT-qPCR and transcriptome analysis’ section.
Gene expression data have been deposited in GEO (Gene Expression Omnibus) under accession code GSE54591. The authors declare that all other data supporting the findings of this study accompany the article and its Supplementary Information Files, or are available from the corresponding author on reasonable request.
How to cite this article: Cerdá-Esteban, N. et al. Stepwise reprogramming of liver cells to a pancreas progenitor state by the transcriptional regulator Tgif2. Nat. Commun. 8, 14127 doi: 10.1038/ncomms14127 (2017).
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Gene Expression Omnibus
Graf, T. & Enver, T. Forcing cells to change lineages. Nature 3, 587–594 (2009).
Jopling, C., Boue, S. & Izpisua Belmonte, J. Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nat. Rev. Mol. Cell Biol. 12, 79–89 (2011).
Slack, J. M. Metaplasia and transdifferentiation: from pure biology to the clinic. Nat. Rev. Mol. Cell Biol. 8, 369–378 (2007).
Vierbuchen, T. & Wernig, M. Direct lineage conversions: unnatural but useful? Nat. Biotechnol. 29, 892–907 (2011).
Heinrich, C., Spagnoli, F. & Berninger, B. Recent breakthroughs and future challenges in in vivo reprogramming for tissue repair. Nat. Cell Biol. 17, 204–211 (2015).
Al-Hasani, K. et al. Adult duct-lining cells can reprogram into beta-like cells able to counter repeated cycles of toxin-induced diabetes. Dev. Cell 26, 86–100 (2013).
Baeyens, L. et al. Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice. Nat. Biotechnol. 32, 76–83 (2014).
Bonner-Weir, S. et al. In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl Acad. Sci. USA 97, 7999–8004 (2000).
Bramswig, N. C. et al. Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming. J. Clin. Invest. 123, 1275–1284 (2013).
Chera, S. et al. Diabetes recovery by age-dependent conversion of pancreatic δ-cells into insulin producers. Nature 514, 503–507 (2014).
Hesselson, D., Anderson, R. M. & Stainier, D. Y. Suppression of Ptf1a activity induces acinar-to-endocrine conversion. Curr. Biol. 21, 712–717 (2011).
Lee, J. et al. Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells. Elife 2, e00940 (2013).
Thorel, F. et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 464, 1149–1154 (2010).
Yang, Y. P., Thorel, F., Boyer, D. F., Herrera, P. L. & Wright, C. V. Context-specific alpha- to-beta-cell reprogramming by forced Pdx1 expression. Genes Dev. 25, 1680–1685 (2011).
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D. A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455, 627–632 (2008).
Horb, M. E., Shen, C. N., Tosh, D. & Slack, J. M. Experimental conversion of liver to pancreas. Curr. Biol. 13, 105–115 (2003).
Banga, A., Akinci, E., Greder, L. V., Dutton, J. R. & Slack, J. M. In vivo reprogramming of Sox9+ cells in the liver to insulin-secreting ducts. Proc. Natl Acad. Sci. USA 109, 15336–15341 (2012).
Ferber, S. et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat. Med. 6, 568–572 (2000).
Wang, A. Y., Ehrhardt, A., Xu, H. & Kay, M. A. Adenovirus transduction is required for the correction of diabetes using Pdx-1 or Neurogenin-3 in the liver. Mol. Ther. 15, 255–263 (2007).
Yechoor, V. et al. Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes. Dev. Cell 16, 358–373 (2009).
Miyatsuka, T. et al. PDX-1 in liver initiates endocrine and exocrine pancreas differentiation but causes dysmorphogenesis. Biochem. Biophys. Res. Commun. 310, 1017–1025 (2003).
Yi-Ju Chen, Y. et al. De novo formation of insulin-producing ‘Neo-β Cell Islets’ from intestinal crypts. Cell Rep. 6, 1046–1058 (2014).
Puri, S. & Hebrok, M. Cellular plasticity within the pancreas- lessons learned from development. Dev. Cell 18, 342–356 (2010).
Zaret, K. & Grompe, M. Generation and regeneration of cells of the liver and pancreas. Science 322, 1490–1494 (2008).
Rodríguez-Seguel, E. et al. Mutually exclusive signaling signatures define the hepatic and pancreatic progenitor cell lineages divergence. Genes Dev. 27, 1932–1946 (2013).
Si-Tayeb, K., Lemaigre, F. & Duncan, S. Organogenesis and development of the liver. Dev. Cell 18, 175–189 (2010).
Xu, C. R. et al. Chromatin ‘prepattern’ and histone modifiers in a fate choice for liver and pancreas. Science 332, 963–966 (2011).
Spagnoli, F. M. & Brivanlou, A. H. The Gata5 target, TGIF2, defines the pancreatic region by modulating BMP signals within the endoderm. Development 135, 451–461 (2008).
Cerda-Esteban, N. & Spagnoli, F. Glimpse into hox and tale regulation of cell differentiation and reprogramming. Dev. Dyn. 243, 76–87 (2014).
Moens, C. B. & Selleri, L. Hox cofactors in vertebrate development. Dev. Biol. 291, 193–206 (2006).
Melhuish, T. A., Gallo, C. M. & Wotton, D. TGIF2 interacts with histone deacetylase 1 and represses transcription. J. Biol. Chem. 276, 32109–32114 (2001).
Mar, L. & Hoodless, P. A. Embryonic fibroblasts from mice lacking Tgif were defective in cell cycling. Mol. Cell Biol. 26, 4302–4310 (2006).
Powers, S. et al. Tgif1 and Tgif2 regulate Nodal signaling and are required for gastrulation. Development 137, 249–259 (2010).
Kim, S. et al. Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus. Nat. Genet. 30, 430–435 (2002).
Tremblay, K. D. & Zaret, K. S. Distinct populations of endoderm cells converge to generate the embryonic liver bud and ventral foregut tissues. Dev. Biol. 280, 87–99 (2005).
Ryder, E. et al. Molecular characterization of mutant mouse strains generated from the EUCOMM/KOMP-CSD ES cell resource. Mamm. Genome 24, 286–294 (2013).
Hayashi, S., Lewis, P., Pevny, L. & McMahon, A. Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain. Mech. Dev. 119, S97–S101 (2002).
Choi, E. et al. Dual lineage-specific expression of Sox17 during mouse embryogenesis. Stem Cells 30, 2297–2308 (2012).
Engert, S., Burtscher, I., Kalali, B., Gerhard, M. & Lickert, H. The Sox17CreERT2 knock-in mouse line displays spatiotemporal activation of Cre recombinase in distinct Sox17 lineage progenitors. Genesis 51, 793–802 (2013).
Kanai-Azuma, M. et al. Depletion of definitive gut endoderm in Sox17-null mutant mice. Development 129, 2367–2379 (2002).
Spence, J. R. et al. Sox17 regulates organ lineage segregation of ventral foregut progenitor cells. Dev. Cell 17, 62–74 (2009).
D’Amour, K. et al. Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 24, 1392–1401 (2006).
Nostro, M. et al. Stage-specific signaling through TGF-beta family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development 138, 861–871 (2011).
Takebe, T. et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499, 481–484 (2013).
Esni, F., Stoffers, D., Takeuchi, T. & Leach, S. Origin of exocrine pancreatic cells from nestin-positive precursors in developing mouse pancreas. Mech. Dev. 121, 15–25 (2004).
Huch, M. et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160, 2990312 (2015).
Michalopoulos, G. K. Liver regeneration. J. Cell Physiol. 213, 286–300 (2007).
Fougère-Deschatrette, C. et al. Plasticity of hepatic cell differentiation: bipotential adult mouse liver clonal cell lines competent to differentiate in vitro and in vivo. Stem Cells 24, 2098–2109 (2006).
Dorrell, C. et al. Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice. Genes Dev. 25, 1193–1203 (2011).
Greggio, C. et al. Artificial three-dimensional niches deconstruct pancreas development in vitro. Development 140, 4452–4462 (2013).
Bort, R., Signore, M., Tremblay, K., Martinez Barbera, J. & Zaret, K. Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development. Dev. Biol. 290, 44–56 (2006).
Yoshioka, M., Kayo, T., Ikeda, T. & Koizumi, A. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46, 887–894 (1997).
Yanger, K. et al. Robust cellular reprogramming occurs spontaneously during liver regeneration. Genes Dev. 27, 719–724 (2013).
Carpentier, R. et al. Embryonic ductal plate cells give rise to cholangiocytes, periportal hepatocytes, and adult liver progenitor cells. Gastroenterology 141, 1432–1438 (2011).
Kopp, J. L. et al. Sox9+ ductal cells are multipotent progenitors throughout development but do not produce new endocrine cells in the normal or injured adult pancreas. Development 138, 653–665 (2011).
Lee, J. et al. Activation of innate immunity is required for efficient nuclear reprogramming. Cell 151, 547–558 (2012).
Seymour, P. A. et al. A Sox9/Fgf feed-forward loop maintains pancreatic organ identity. Development 139, 3363–3372 (2012).
Cebola, I. et al. TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors. Nat. Cell Biol. 17, 615–626 (2015).
Richard, J. P. et al. Direct in vivo cellular reprogramming involves transition through discrete, non-pluripotent steps. Development 138, 1483–1492 (2011).
Kragl, M. et al. Cells keep a memory of their tissue origin during axolotl limb regeneration. Nature 460, 60–65 (2009).
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W. & Roder, J. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl Acad. Sci. USA 90, 8424–8428 (1993).
Petzold, K. & Spagnoli, F. A system for ex vivo culturing of embryonic pancreas. J. Vis. Exp. 66, e3979 (2012).
Pfaffl, M. W., Horgan, G. W. & Dempfle, L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36 (2002).
Burtscher, I. & Lickert, H. Foxa2 regulates polarity and epithelialization in the endoderm germ layer of the mouse embryo. Development 136, 1029–1038 (2009).
Smyth, G. K. Bioinformatics and Computational Biology Solutions using R and Bioconductor 397–420Springer (2005).
Nogales-Cadenas, R. et al. GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res. 37, W137–122 (2009).
Borg, D. et al. Mesenchymal stromal cells improve transplanted islet survival and islet function in a syngeneic mouse model. Diabetologia 57, 522–531 (2014).
We thank Klaus Rajewsky, Norbert Hübner and all members of the Spagnoli lab for helpful discussions and reading of the manuscript. We thank the MDC FACS Core Facility and Dr Hans-Peter Rahn for assistance. We are grateful to P. Hoodless for the TGIF1tm1aPah mouse strain and M. Wegner for the anti-Sox9 antibody. This research was supported by institutional funds from the Helmholtz Association and ERC-Starting HEPATOPANCREATIC Grant (#243045).
The authors declare no competing financial interests.
About this article
Cite this article
Cerdá-Esteban, N., Naumann, H., Ruzittu, S. et al. Stepwise reprogramming of liver cells to a pancreas progenitor state by the transcriptional regulator Tgif2. Nat Commun 8, 14127 (2017). https://doi.org/10.1038/ncomms14127
This article is cited by
Stem Cell Reviews and Reports (2022)
Stem Cell Research & Therapy (2020)
Nature Reviews Endocrinology (2020)
TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness
Signal Transduction and Targeted Therapy (2019)
Current Diabetes Reports (2019)